A new in vivo pharmacokinetic recall study involving 114 participants in the Estonian Biobank has provided the first clinical ...
MD Anderson studies reveal how cancer cells rewire metabolism to spread. A glucose–fructose mix promotes colorectal ...
Fat jabs could be triggering a surge in Brits needing their gallbladders removed, a shock investigation revealed today. ...
A study based on data from the Estonian Biobank shows that previously unstudied genetic variants may slow the breakdown of medications, leading to their buildup in the body. The risk of side effects ...
15hon MSN
The rise of ‘agonorexia’: People are developing brand new eating disorders on GLP-1 agonist drugs
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...
In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented ...
The global demand for effective obesity treatments has been surging, with a market size projected to reach USD 60.53 billion by 2030, yet latest therapies including GLP-1 receptor agonists (GLP-1RAs) ...
Join this energizing yoga session designed to build full-body strength, increase flexibility, and support your metabolism.
Over time, these cascading effects contribute to a growing burden on the person, their family and the health-care system. As ...
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...
Plus, what a doctor has to say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results